Insilico Medicine launches new system for COVID-19 basic and clinical research
Today Insilico Medicine, a global leader in artificial intelligence for drug discovery and development, announced the launch of a new system for COVID-19 basic and clinical research.
No hay comentarios:
Publicar un comentario